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Research in the genetics of hearing and deafness has evolved rapidly over the past years, providing the
molecular foundation for different aspects of the mechanism of hearing. Considered to be the most common
sensory disorder, hearing impairment is genetically heterogeneous. The multitude of genes affected encode
proteins associated with many different functions, encompassing overarching areas of research. These
include, but are not limited to, developmental biology, cell biology, physiology, and neurobiology. In this
review, we discuss the broad categories of genes involved in hearing and deafness. Particular attention is
paid to a subgroup of genes associated with inner ear gene regulation, fluid homeostasis, junctional complex
and tight junctions, synaptic transmission, and auditory pathways. Overall, studies in genetics have provided
research scientists and clinicians with insight regarding practical implications for the hearing impaired, while
heralding hope for future development of therapeutics.Causes of Hearing Loss
Similar to other sensory loss, hearing impairment has a wide
spectrum of etiologies originating from both environmental and
genetic factors. Prolonged exposure to high intensity sound
poses high risk for auditory function and can lower hearing
thresholds. Acoustic trauma, as a result of a sudden loud noise,
can lead to temporary and/or permanent hearing impairment.
Among environmental factors, different viral infections, as well
as neonatal anoxia and hyperbilirubinemia, can also cause
permanent hearing defects. Long-term augmentation of ototoxic
drugs such as aminoglycoside and gentamicin antibiotics has
an adverse effect on the auditory system and accounts for
hearing defects (Yorgason et al., 2006). Unlike the genetics
factors dictated by hereditary information, some of the environ-
mental factors can be reduced or prevented by raising aware-
ness for appropriate protection.
Genetic insults contributing to hearing defects poses greater
challenges. The clinical heterogeneity of hearing loss is charac-
terized by common classifications based on several parameters
such as onset, severity, and the presence of additional clinical
manifestations other than deafness. Hearing loss that occurs
prior to speech acquisition is termed prelingual deafness, either
congenital or appearing after birth. A hearing disability that
appears early in childhood can have a major consequence on
language acquisition. Age-related hearing loss (ARHL) affects
the elderly population with high prevalence, and its appearance
and progression is influenced by both genetic and environmental
factors (Cruickshanks et al., 1998; Gates et al., 1999). About
60% of the population over the age of 65 suffers from different
degrees of hearing loss, with a decline in sensitivity to sound,
accompanied with reduced speech perception. Hearing loss is
also categorized based on the frequency loss and the severity
of hearing thresholds. High tone loss refers to reduced sensitivity
of high-frequency acoustic stimulus, as opposed to low tone loss
for the low frequencies. The terms profound, mild, andmoderate
describe the descending order of different severity levels ofhearing impairments. When hearing loss is the only apparent
abnormality, it is referred to as nonsyndromic hearing loss
(NSHL). In other cases hearing loss occurs along with a variety
of other malformations and thus is designated as syndromic
hearing loss (SHL).
Overview of the Hearing Mechanism
The auditory system bears one of themost intricate mechanisms
of sensation ability in humans. The inner ear, a fluid-filled organ,
is responsible for transforming the mechanical energy of the
sound waves into electrical stimuli, which will eventually be
translated in the brain. Anatomically, the inner ear is divided
into the auditory and vestibular systems. While the auditory
system is responsible for sound sensation, the vestibular system
is responsible for three-dimensional orientation and gravity
perception. The similarities between these two systems often
lead to balance disorders in hearing impaired individuals (Gresty
and Brookes, 1997). The auditory system is composed of a
snail-shaped cochlea. The cochlea is a fluid-filled tube coiled
in a spiral shape around the modiolus (Figure 1). Upon viewing
a longitudinal cross-section, the cochlear canal is divided into
three compartments (scalae). The scala media filled with endo-
lymph lies between two larger perilymphatic filled compart-
ments, the scala vestibuli and scala tympani.
The scala media contains the cochlear sensory epithelium, the
organ of Corti, which sits on top of the basilar membrane (Corti,
1851). The organ of Corti contains specialized sensory cells,
known as hair cells, arranged in three rows of outer hair cells
(OHCs) and one row of inner hair cells (IHC). The tectorial
membrane, which sits on top of the organ of Corti, is an extracel-
lular auxiliary structure contributing to hair-cell excitation
(Lukashkin et al., 2010). Sound-induced mechanical vibration
of the middle ear is transmitted to the cochlea, generating
movements of its associated fluids (Lawrence et al., 1961). As
a consequence, deflection of the basilar membrane activates
the sensory cells that transduce the mechanical stimulationNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 293
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Figure 1. Schematic Illustration of the
Mammalian Inner Ear
(A) The ear is composed of the external, middle,
and inner ear. Thecochlea, responsible for hearing,
and the vestibule, responsible for balance, make
up the inner ear.
(B) A cross-section of the cochlear duct reveals
the scala media, scala tympani and scala vestibuli
that are filled with fluids, as well as the tectorial
membrane (TM) over the organ of Corti.
(C) An enlargement of the organ of Corti, the
cochlear sensory epithelium, showing three rows
of OHCs and one row of IHCs, flanked by various
types of supporting cells.
(D) The hair bundle of an OHC showing the actin-
based stereocilia organized in a staircase pattern.
(E) Scanning electron microscopy (SEM) image
showing the hair bundle of an OHC of a mouse,
analogous to the scheme in (D) (our unpublished
data).
(F) Immunofluorescence confocal images of IHCs
and OHCs of a mouse, with expression of myosin
VI (red) in the cytoplasm and the nucleus marked
by DAPI (blue), analogous to the scheme in (C)
(our unpublished data).
(A–D) Adapted from Dror and Avraham (2009).
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Reviewinto electrical signal. The number of cochlear turns, combined
with the graded length and stiffness of the basilar membrane
along the length of the cochlea, contributes to the determination
of the audible range of frequencies (Manoussaki et al., 2006).
The cochlear hair cells have a substantial role in translating
mechanical forces evoked by sound into an electrical signal.
The apical surface of each hair cell contains protrusions of
actin-rich filaments known as stereocilia, which play a pivotal
role in this mechanism. These membrane-bound filaments
form a typical staircase arrangement, stabilized by a rich network
of interconnections. Most significant, a tip link is present
between the tops of stereocilia in the upper row of the hair bundle
to the tips of stereocilia on the next lower row (Kazmierczak et al.,
2007; Pickles et al., 1984). Upon mechanical stimulation that
force deflections of the hair bundles, the tip links trigger the294 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.opening of the mechanoelectrical trans-
duction (MET) channels that are located
at stereocilia tips across the bundle. The
synchronized opening of the MET chan-
nels depolarizes the cells and initiates
electrical signals to the auditory nerve.
The hair bundles of the cochlear hair cells
face the scala media immersed in its
fluid, the endolymph. Unlike other physio-
logical fluids in the human body, the
endolymph has a unique electrolyte
composition with high potassium (K+)
and low sodium (Na+) concentrations
(Wangemann and Schacht, 1996). When
hair cells are mechanically excited, an
influx of potassium (K+) and calcium
(Ca2+) ions depolarize the cell and trigger
the release of neurotransmitter at the
basal pole of the hair cell (Dallos, 1996).Theafferent auditorypathwayconnects the sensorymachinery
of the cochlea to the brain, paving the route for propagation of
neuronal electrical signals evoked by an acoustic stimulus. The
apical side of cochlear hair cells is responsible for their mechano-
sensory role mediated by hair bundles, whereas the basolateral
side of the cell is responsible for synaptic transmission. Thus,
IHCs also function as presynaptic terminals, by coding acoustic
signals to neurotransmitter release onto auditory afferent nerve
fibers (Fuchs, 2005). Specialized ribbon synapses located at
presynaptic active zones of IHCs are tethered by synaptic vesi-
cles and are sufficient for their precise temporal release in
response to sound (Glowatzki et al., 2008). IHCs serve as the
major acoustic sensors, whereas the OHCs increase amplifica-
tion sensitivity and frequency selectivity of the cochlea (Dallos,
1992). Each IHC is innervated by more than 15 afferent sensory
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Figure 2. The Chromosomal Location of Genes with Mutations Causing Hearing Impairment
The genes are classified as nonsyndromic autosomal recessive (red), nonsyndromic autosomal dominant (blue), x-linked (black), syndromic (green), and genes
that are associated with both syndromic and nonsyndromic hearing loss (light blue). Data was taken from the Hereditary Hearing Loss Homepage.
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Reviewneurons, providing efficient parallel channels for transmission of
an acoustic stimulus to the central nervous system (Rubel and
Fritzsch, 2002). The primary electrical signal initiated by the
IHCs is processed in the spiral ganglia, the auditory nerve, and
integrated in the afferent auditory pathway. Further downstream
to the auditory nerve, the auditory pathway contains four major
intermediate stations, including the cochlear nuclei, superior
olive, inferior colliculus, and medial geniculate body (Webster,
1992). In the brain, the collected auditory inputs are decoded
and analyzed within the auditory cortex in the temporal lobe.
The cochlear hair cells are arranged in a tonotopic gradient that
enables acquisition of sensory transduction of the audible range
of frequencies. This organization is characterized by a gradient
along the length of the cochlea, sensing high frequencies at
the base and low frequencies at the apex (Romand, 1997). Like-
wise, further communication of acoustic signals with the brain is
tonotopically preserved within the different levels of the auditorypathway (Rubel and Fritzsch, 2002). This high selectivity and
sensitivity for frequency specific signals provides us with the
ability of orchestrated perception to decipher between a rich
spectrum of sounds.
Inroads into the Genetics of Hearing and Deafness
Given the complexity of the hearing mechanism, it should come
as no surprise that a panoply of genes have been discovered to
be involved in hearing loss. To date, more than 50 genes and 80
additional loci have been linked to various degrees of hearing
impairment (Figure 2). Taking advantage of standardized nomen-
clature, a common classification of the loci and genes for
hearing impairment has been established (HUGO Gene Nomen-
clature Committee, http://www.genenames.org/). Depending on
the inheritance mode, the nonsyndromic genes or loci are clas-
sified accordingly: DFNA (dominant), DFNB (recessive), DFNX
(x-linked), DFNY (y-linked), and DFNM (modifier). AdditionalNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 295
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Reviewspecific symbols are used for different forms of hearing loss
including otosclerosis (OTSC), auditory neuropathy (AUNA),
and mitochondrial (MRTNR, MTTS) genes. For each locus,
the relevant symbol is depicted with a number next to it,
designated by the chronological order of its discovery. Routinely
updated, the Hereditary Hearing Loss Homepage (http://
hereditaryhearingloss.org/) provides an open and reliable
resource for all listed genes and loci. Well-established genetic
studies from the past years have highlighted the pathophysiol-
ogies underlying mutations in many of these genes (Dror and
Avraham, 2009). Several studies have successfully integrated
groups of proteins encoded by these genes into common
pathways of inner ear function, providing explanations for the
similar phenotypes of affected individuals carrying mutations
in different genes of the same network. One such example is
the Usher network of proteins, with mutations in nine different
genes underlying this most common syndrome of deafness
and blindness (Saihan et al., 2009) Nevertheless, human variants
of the same gene may result in clinical heterogeneity. For
example, mutations in the SLC26A4 gene are linked with either
NSHL, DFNB4, or a syndromic form known as Pendred’s
syndrome (PS) with enlargement of the thyroid gland (Pera
et al., 2008).
The attempt to identify genes for hearing impairment by
conventional methods has led to great success over the past
two decades. Linkage analysis with microsatellite markers has
been used widely, allowing the chromosomal location of deaf-
ness genes to be mapped in families all over the world. Once
the linkage region was elucidated, in the most recent years,
mutation analysis by Sanger sequencing often led to the identi-
fication of the causative mutation. However, despite the great
contribution of linkage analysis methods, many deafness genes
remain to be elucidated. A long list of human loci linked with
hearing impairment is still pending for further gene discovery
(Hereditary Hearing Loss Homepage). Furthermore, complex
mutations such as duplications of an entire gene within a detec-
tive locus could not be assessed by standard sequencing
approaches. For example, taking advantage of array compara-
tive genomic hybridization (array CGH), geneticists can track
chromosomal imbalances. Utilizing this platform, a tandem
genomic duplication of the TJP2 gene was recently identified
to be responsible for progressive NSHL in DFNA51 individuals
(Walsh et al., 2010a). Both the DFNB79 and DFNB82 genes,
encoding taperin and GPSM2, respectively, were identified by
targeted genome capture, combined with massively parallel
sequencing (Rehman et al., 2010; Walsh et al., 2010b). With
the development of advanced new technologies such as
massively parallel sequencing, it is expected that more genes
will be added to the list of human genes for hearing impairment
in a relatively short period.
Animal models have provided an invaluable tool for studying
advanced hearing mechanisms in a way that could not have
been achieved only by human studies. A wide array of organ-
isms, including zebrafish, chick, and mouse, have comple-
mented the human genetics field with an in-depth understanding
of protein function. Among the models, the striking similarity
between human and mouse inner ear structure and function
has defined the mouse as a prominent animal model for human296 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.deafness. The ease of gene overexpression, depletion, and tar-
geted mutagenesis has enabled researchers to create reliable
animal models for genetic forms of hearing loss to mimic the
corresponding mutation in humans. Once a novel human deaf-
ness gene is discovered, the generation of an animal model is
optimal for studying its function. Thus, in parallel to gene
discovery in human families, a long list of mouse models for
hearing loss have been established (Leibovici et al., 2008). This
tight crosstalk between human and mouse genetics also bene-
fits in the other directions, from mouse to human (Brown et al.,
2008). Mutants that have arisen due to spontaneous mutations
and chemically induced mutants generated by N-ethyl-N-nitro-
sourea (ENU) mutagenesis have led to the discovery of new
deafness genes in mice and subsequent discovery of their
human orthologs (Brown et al., 2009). For example, identification
of a recessive mutation in the Loxhd1 gene of the samba deaf
ENU mice led to the discovery of its human ortholog LOXHD1
within the previously mapped DFNB77 locus responsible for
autosomal recessive NSHL (Grillet et al., 2009). This pheno-
type-driven approach has not only enriched the list of known
deafness genes, but also enabled scientists to further study
the pathophysiology underlying different mutations. The avail-
ability of state-of-the-art scientific tools, including in vivo studies
on animal models, has opened a new venue for understanding
the complex mechanisms of proteins in the wide context of the
auditory network.
Molecular Pathways andGenes Involved in Hearing Loss
Gene discovery in humans and protein characterization in
animal models have revealed numerous molecular pathways in
the inner ear. These include but are not limited to gene regula-
tion, fluid homeostasis, mechanotransduction, and structure
(Figure 3).
Gene regulation plays an essential role in development. It is
therefore not surprising that numerous transcription factors,
including EYA4, POU3F4, POU4F3, TFCP2L3, and ESRRB,
have been linked with hearing loss. Recently, a mutation in the
microRNA miR-96 was also implicated in progressive hearing
loss in humans, introducing the first microRNA deafness gene
(Mencı´a et al., 2009). miR-96 resides within a cluster of three
miRNAs, while the other two, miR-183 and miR-182, are also
expressed in the inner ear and participate in the regulation of
gene expression (Figure 4; Weston et al., 2006).
A wide number of genes encoding different transporters and
channels are highly expressed in the ear and participate in
maintaining the unique fluid homeostasis (Lang et al., 2007).
The critical nature of maintaining appropriate fluid homeostasis
is highlighted by evidence that mutations in genes such as the
solute carrier transporter gene SLC26A4 (pendrin) lead to
prelingual deafness. Constant secretion of potassium into the
endolymph and generation of endochlear potential is also para-
mount for inner ear physiology and requires potassium recycling
machinery (Zdebik et al., 2009), with a network of connexin gap
junction proteins suggested to support this process.
The compartmentalization of the two distinct extracellular
fluids of the inner ear, endolymph and perilymph, requires
a network of epithelia to establish a tight junctional barrier
surrounding the scala media (endolymph). In this regard, a group
Tight
junctions
Mechanoelectrical
transduction (MET)
channels 
Tip link
(Cadherin 23 and
protocadherin 15)
Extracellular
matrix proteins
Collagen XI
α-tectorin
Supporting cell
Outer
hair cell
(OHC)
Outer
hair cell
(OHC)
Connexin 26/connexin 30
(gap junction)
K+
K+
K+
K+
K+ K
+
K+
K+
K+
K+
K+
K+
K+K+
endolymph
high (K+)Tight 
junctional
barrier
miR96
Pou4f3 
Claudin-14
Tjp2
perilymph
perilymph
StereociliaDeﬂect
Hair bundle
Cuticular
plate
Ac
tin
 ﬁ
la
m
en
ts
TM
Stria vascularis
Marginal
cells
(K
+ ) c
yc
le
Intermediate
cells
NR3B2 (TF)
Kcnq1/
Kcne1
K+
K+K+
K+
K+
K+
K+
K+
Na +
K+
K+K+
K+
En
do
lym
ph
Kc
nj1
0K+
Na +
Efferent
Ribbon synapse
Stereocilia
Otoferlin and VGLUT3
Afferent
Inner
hair cell
(IHC)
miR96
Pou4f3 
Tectorial membrane (TM)
K+-rich endolymph
D E
C A
F
GB
Figure 3. Schematic Illustration of Components of Hearing Mechanisms, Highlighting Genes Underlying Hearing Loss in Humans and Mice
(A) To support the unique endolymphatic fluid composition, a tight junctional barrier (dashed purple line) between epithelial cells of the scalamedia (endolymph) is
established by different junctional complex proteins. This network of epithelia prevents leakage of the high potassium concentration that is constantly secreted
into the endolymph by the (K+) recycling machinery.
(B) At the lower part of the inner hair cell within the basal pole, a dense structure of ribbon synapse is tethered by a pool of synaptic vesicles ready to be released.
A mechanosensory hair bundle on the apical side of the cells responds to an acoustic stimulus that depolarizes the cell, triggering secretion of synaptic vesicles.
(C) The cochlear hair cells are neighboring with supporting cells that establish a route for potassium ion propagation as part of its recycling machinery. Efflux of
potassium outside the cell is supported by (K+) channels and is crucial in order to bring the cell back to the excitatory condition.
(D) The apical surface of the hair cells is immersed within the endolympahtic fluids and is thus sensitive to its mechanical movements that are evoked by sound.
Deflection of the hair bundle stretches tip links between stereocilia and triggers the opening of the MET channels, followed by influx of potassium ions that
depolarize the cells. The tight junction barrier between hair cells and supporting cells prevents ion leakage from the K+ rich endolymph and maintains selective
paracellular transport.
(E) The tip links between actin-rich stereocilia are assembled with two adhering proteins. Other lateral links between sterocilia are essential for the cohesion and
stability of the hair bundle.
(F) The stria vasularis, located at the lateral wall of the scala media, is essential for the secretion of (K+) into the endolymph and for maintaining its associated
endocochlear potential. The stria marginal and intermediate cells are rich with transporters and channels that support and maintain the homeostasis of the
endolymph.
(G) The tectorial membrane (TM) is an auxiliary structure composed of extracellular matrix and contributes to hair cell excitation. Its integrity is highly depended on
the temporal and spatial secretion of it associated proteins.
Adapted from Dror and Avraham (2009).
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Reviewof genes encoding tight junction proteins, including CLDN14,
TRIC, and TJP2, participates in the formation of the mechanical
barrier between epithelial cells in the inner ear. These genes havealso been implicated in different forms of hearing impairment and
their functional significance in hearing is outlined, including
barrier formation, cell polarization, and signal transduction.Neuron 68, October 21, 2010 ª2010 Elsevier Inc. 297
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Figure 4. A Sampling of Expression in the Inner Ear and
Morphological Defects in Deaf Mouse Mutants
(A) RNA in situ hybridization of microRNA-182 shows strong expression in the
inner and outer hair cells of the cochlea (left panel), as well as in vestibular hair
298 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.
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ReviewThe inner ear is responsible for transforming the mechanical
energy of the sound waves into electrical stimuli, and its function
relies critically on the integrity of the extracellular matrix of the
tectorial membrane and the basilar membrane in order to
achieve proper mechanical stimulation of the cochlear sensory
cells. This process depends upon on the appropriate temporal
and spatial expression patterns of the participating matrix
proteins (Richardson et al., 2008). Accordingly, several extracel-
lular matrix proteins encoded by TECTA (a-tectorin), COL11A2
(collagen, type XI, alpha 2), COCH (cochlin), OTOA (otoancorin),
and STRC (stereocilin) have been associated with different forms
of hearing impairment.
The inner ear also expresses another prominent group of
genes belonging to the myosin family of motor proteins,
including MYO1A, MYO3A, MYO6, MYO7A, MYO15A, and
MYH9 (Petit and Richardson, 2009). Hair cell-specific myosins
were shown to have a crucial role in hair bundle organization
and function. Human mutations of these myosins are associated
with NSHL, whileMYO7Amutations can also lead to a syndromic
form of blindness and deafness known as Usher syndrome.
Human mutations in several additional genes have also been
linked to familial cases of Usher syndrome, while their encoded
proteins are essential for the morphogenesis and cohesion of
hair bundles of cochlear hair cells (Saihan et al., 2009). Four of
these genes, CDH23, PCDH15, USH2A, and VLGR1, encode
adhesion proteins; three genes, WHRN, USH1C, and SANS,
encode scaffolding proteins; and the USH3A gene encodes an
integral protein. The cell-cell adhesion proteins cadherin 23
(CDH23) and protocadherin 15 (PCDH15) form the tip link
between adjacent stereocilia (Kazmierczak et al., 2007) and
support themechanical tension of the hair bundle and its mecha-
notransduction, with mutations in these genes causing NSHL or
Usher syndrome (Ahmed et al., 2003; Bork et al., 2001). More
details on these genes and their roles in deafness have been
reviewed in detail elsewhere (Gillespie and Mu¨ller, 2009).
Finally, the normal function of the auditory system also
depends critically on its ability to transduce mechanical stimuli
into an electrical signal that appropriately propagates from the
cochlea to the brain. Mutations in genes that are critical to thiscells in the sensory epithelium of the crista (right panel). microRNA-182 is also
expressed in the spiral ganglia of the cochlea (our unpublished data).
(B) A Dicer-PCKO mouse at p38, lacking microRNAs in the hair cells, has
rounded hair bundles as opposed to the V-shape hair bundle of a wild-type
mouse that shows an organized staircase structure of sterocilia, demonstrated
by SEM (Friedman et al., 2009).
(C) Pendrin defects in the Slc26a4loopmutant leads to hydrops of the endolym-
pahtic labyrinth, demonstrated by paint filled inner ears. A prominent bulged
cochlea (co) and endolymphatic sac (es) and duct is observed in the mutant
(our unpublished data).
(D) Impaired transport activity of pendrin in the Slc26a4loop mutant leads to
formation of giant calcium oxalate mineralized bodies in the inner ear (Dror
et al., 2010).
(E) Snell’s waltzer (svMyo6) mice are null for the myosin VI protein and their
cochleas lacks the normal cohesion and polarity of hair bundles, along with
inconsistent direction of sterocilia protrusions (our unpublished data).
(F) The Usher syndrome III mouse model (USH3A) depleted of Clrn1 shows
severely disorganized hair bundles of inner hair cells with fused actin stereoci-
lia (red) and altered size and shape of cuticular plate, detected by immunos-
taining against myosin VI (green) (our unpublished data).
Scale bars: In (A), 50 mm; in (B), 2 mm; in (C), 1 mm; in (D), 2 mm, 100 mm; in (E),
5 mm; (F), 2 mm.
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Reviewsynaptic transmission process, such as SLC17A8 (VGLUT3) and
OTOF (otoferlin), can lead to deafness, including a relatively rare
hearing disorder, auditory neuropathy, associated with improper
functioning of the auditory nerve.
In the current review we have focused on a subgroup of genes
encoding proteins associated with different aspects of auditory
function, including gene regulation, fluid homeostasis, junctional
complex and tight junctions, synaptic transmission, and the
auditory pathway. Individual genes and pathways have been
chosen as a way to highlight the types of processes critical for
proper auditory function, and illustrates how alterations in these
gene products can lead to hearing impairment.
Gene Regulation
Temporal and spatial regulation of gene expression is funda-
mental for development, cellular proliferation and differentiation,
morphogenesis, and drives the specific function of different cells
and tissues (Latchman, 2007). A large group of regulatory
proteins, including transcription factors (TFs) that bind to
specific DNA sequences, regulate the precise transcription of
a gene into RNA molecules and are therefore critically involved
in many aspects of cellular development and function. Not
surprisingly, mutations in TF genes have been detected in
patients with a variety of different hereditary clinical conditions.
Among the long list of deafness genes, several TFs harbor muta-
tions that lead to multiple forms of hearing loss. Two of these,
POU3F4 and POU4F3, belong to the family of POU homeodo-
main trans-regulatory factors. In addition to their homeodomain,
a second DNA-binding region, the POU domain, enhances
the specificity to certain DNA sequences (Herr et al., 1988).
POU3F4 underlies X-linked DFNX2 (de Kok et al., 1995). Tar-
geted mutagenesis of Pou3f4 in mice leads to developmental
defects of the auditory system (Phippard et al., 1999). Mutations
in POU4F3 underlie progressive hearing loss in humans
(DFNA15) and affect its transcription activity and nuclear locali-
zation in the inner ear (Collin et al., 2008a; Vahava et al., 1998;
Weiss et al., 2003). Pou4f3 knockout mice are deaf due to the
loss of cochlear hair cells (Erkman et al., 1996). In the mouse
inner ear, Pou4f3 is highly expressed in sensory hair cell nuclei
and is essential for their maturation and survival (Xiang et al.,
1998). Transcription profiling of Pou4f3 mutant mice identified
several downstream targets of Pou4f3 in the inner ear including
Gfi1 and Lhx3 (Hertzano et al., 2004). Recent work has demon-
strated the potential treatment of antiapoptotic factors that
mediate the survival of auditory hair cells derived from the
Pou4f3 mutant (Atar and Avraham, 2010). The EYA4 transcrip-
tional activator has an important role during the maturation of
the organ of Corti, and mutations cause late-onset deafness in
humans (DFNA10) (Wayne et al., 2001). Mutations in another
TF, TFCP2L3, a mammalian ortholog of the Drosophila gene
grainyhead, leads to progressive hearing loss DFNA28 (Peters
et al., 2002). Significantly, a genome-wide association study
suggests that TFCP2L3 gene variants are associated with age-
related hearing impairment in European populations (Van Laer
et al., 2008). In the inner ear Tfcp2l3 shows a broad epithelial
expression pattern by in situ hybridization. Finally, mutations in
ESRRB, a member of the nuclear-hormone-receptor family of
TFs, were linked with autosomal recessive hearing impairmentDFNB35 (Collin et al., 2008b). ESRRB encodes an estrogen-
related receptor beta (NR3B2), characterized by two functional
domains, a DNA-binding domain and a ligand-binding domain.
In the cochlea, it is specifically expressed in the endolymph-
secreting marginal cells of the stria vascularis, controlling the
expression of multiple ion channels essential for endolymph
production (Chen and Nathans, 2007). Most prominent, the
work on different Esrrb mutants mice reveals its function in
controlling epithelial cell fate and fluid homeostasis in the inner
ear.
Since the discovery of microRNAs, their essential role in post-
transcriptional regulation of gene expression has been estab-
lished in diverse processes including development, cellular
signaling pathways, and disease (Kloosterman and Plasterk,
2006). MicroRNAs are short RNA molecules of approximately
21–23 nucleotides that mediate the posttranscriptional repres-
sion of mRNA of protein-coding genes (Bartel, 2009). A critical
seed region within a microRNA is essential for its specific target
recognition and thus mutations within this region are prone to
alter its regulatory role. Recently, two complementary studies
in humans and mice have revealed the first microRNA gene,
miR-96, implicated in hearing loss. Mutations in the seed region
of miR-96 leads to progressive hearing loss in humans under-
lying the DFNA50 locus (Mencı´a et al., 2009). As a result of this
mutation, the biogenesis of miR-96 is disrupted and leads to
a significant reduction of mRNA targeting. Similar to humans,
an ENU-induced mutation of miR-96 in diminuendo (Dmdo)
mice show progressive loss of hearing (Lewis et al., 2009).
Further characterization of inner ear abnormalities of Dmdo
mice include marked degeneration of cochlear hair cells and
fused stereocilia of the remaining hair bundles. miR-96 belongs
to a cluster of three microRNAs that includes miR-183 and
miR-182, with all expressed in inner ear sensory cells, as well
as in spiral ganglion cells. Transcription profiling of Dmdo mice
has revealed altered expression of different genes, including
downregulation of a prominent list of known deafness genes.
Taken together, establishing the transcriptional and posttran-
scriptional regulatory networks of inner ear function may open
a venue for future therapeutic strategies for some forms
of hearing loss, utilizing modulation of gene expression and
translation.
Fluid Homeostasis
Mechanosensory transduction of the auditory hair cells depends
on two pivotal roles of the inner ear extracellular fluids. First, in
response to sound stimulus, the conductive portion of the outer
and middle ears transfer the energy of sound waves to the fluids
within the closed compartment of the inner ear and triggers their
movements. The hair bundles of the sensory hair cells are
immersed within these fluids and are activated upon deflection
as a result of their movement. Second, the unique chemical
composition of the endolymph, with its high potassium (K+)
and low sodium (Na+) concentrations, play a crucial role in hair
cell depolarization. MET channels located within the tip of the
stereocilia of the hair bundle are sensitive to mechanical move-
ments that trigger their opening, allowing (K+) influx into the
hair cells. To support sensory transduction, a large group of
genes encoding potassium channels and transporters, includingNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 299
Neuron
ReviewKCNQ1, KCNE1, KCNQ4, KCNJ10, and SLC12A2, participate in
the critical mechanism of (K+) recycling and its associated high
endocochlear potential (reviewed in Zdebik et al., 2009). Muta-
tions in these genes are associated with either NSHL or SHL of
the affected individuals. A gap junction (GJ) network of several
connexin (Cx) isoforms including GJB2 (Cx26), GJB6 (Cx31),
GJB6 (Cx30), are highly expressed in the ear and suggested to
support the route of potassium recycling (Nickel and Forge,
2008). Human mutations in GJB2 and GJB6 underlie the most
common forms of autosomal recessive deafness, DFNB1A and
DFNB1B (del Castillo et al., 2002; Kelsell et al., 1997). Other con-
nexins are involved in less frequent forms of hearing loss. Along
with the pivotal role of potassium (K+) ions in hearing, maintaining
other electrolytes constituents, as well as controlling the volume
of the extracellular fluids, is no less important for inner ear
physiology and requires the function of additional proteins.
Mutations in the solute carrier transporter gene, SLC26A4,
encoding pendrin, leads to prelingual deafness characterized
by enlarged vestibular aqueduct (EVA). Some mutations can
also lead to PS, a syndromic form of deafness associated with
enlargement of the thyroid gland. Pendrin is expressed in
different tissues including kidney, thyroid and inner ear, where
it functions as a transporter of ions such as chloride (Cl), iodide
(I), and bicarbonate (HCO3
). Functional assays have shown
that different mutations along the pendrin sequence have
different effects on its transport activity and thus can explain
some of the clinical heterogeneity (Pera et al., 2008). In the inner
ear, pendrin is localized to the membrane of different cell types
that face the endolymph, both in the cochlear and vestibular
apparatus. Whereas the number of pendrin transmembrane
domains is still ambiguous in the literature (Dossena et al.,
2009), it is clear that some of the mutations affect pendrin
subcellular localization in a way that it fails to reach the plasma
membrane (Brownstein et al., 2008). Generation of pendrin null
mice has provided a tremendous tool in understanding the
pathophysiology underlying this form of deafness observed in
humans. Slc26a4/ mice show a dramatic enlargement of the
endolymphatic compartments with significant hydrops of the
cochlea, as well as the endolymphatic sac and duct (Everett
et al., 2001). Electrophysiological studies have shown that
absence of pendrin leads to acidification of the endolymph, sug-
gesting that pendrin mediates bicarbonate (HCO3
) secretion in
the inner ear that buffers the accumulation of protons (H+)
(Wangemann et al., 2007). A subsequent increase of endolym-
phatic calcium (Ca2+) ion concentration in pendrin null mice is
attributed to the lower pH level that inhibits the acid-sensitive
TRPV5 and TRPV6 calcium channels (Nakaya et al., 2007).
Pendrin null mice also failed to develop endocochlear potential
and hearing due to the loss of Kcnj10 protein expression after
the age of postnatal day (P)10 (Wangemann et al., 2004). In the
cochlea, Kcnj10, encoding a K+ channel, is normally expressed
in intermediate cells of the stria vascularis and is sufficient
for generating an endocochlear potential. Since pendrin is
expressed in different cell types of the cochlea, its mutation is
suggested to have an indirect effect on Kcnj10 expression. An
observed increased level of oxidative stress in pendrin null
mice impairs normal function of the stria vascularis with subse-
quent loss of Kcnj10 protein expression and lack of endoco-300 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.chlear potential (Singh and Wangemann, 2008). Interestingly,
KCNJ10, together with mutations of SLC26A4, leads to digenic
hearing loss with enlarged vestibular aqueduct (Yang et al.,
2009). Understanding that the pendrin mouse model fails to
develop hearing due to the loss of the endocochlear potential
defines window of opportunities for therapeutic approaches
prior to the loss of KCNJ10 protein expression.
The pendin null mice also show numerous developmental
defects of the inner ear, consistent with cochlear hypothyroidism
(Wangemann et al., 2009). The importance of normal thyroid
function in hearing development and function is well established
and has been studied in several mouse models with thyroid
defects (Knipper et al., 2000; Mustapha et al., 2009; Winter
et al., 2006). Since hypothyroidism has been observed in PS
patients, it raised the question whether this factor contributes
to the development of hearing loss in these affected individuals.
The pendrin null mice were shown to have normal thyroid gland
morphology and histology (Everett et al., 2001), while biochem-
ical tests confirm that this mousemodel is systemically euthyroid
(Wangemann et al., 2009). Nonetheless, it has been proposed
that the enlargement of the scala media distorts reciprocal
epithelial-mesenchymal interactions that can lead to local
hypothyroidism in the inner ear of pendrin null mice that affect
its proper development. Further understanding the contribution
of systemic hypothyroidism in PS patients to their hearing loss
may help to identify a partial treatment based on thyroid
hormone replacement strategies in order to prevent some of
the auditory deformation.
Recent work focused on the vestibular dysfunction of an ENU
mouse mutant for pendrin, loop, demonstrated that impaired
function of pendrin leads to the formation of giant calcium
oxalate stones in the inner ear (Figure 4; Dror et al., 2010). This
unique type of mineral accounts for more than 80% percent of
all kidney stones and its composition in the inner ear was
revealed for the first time. A significant number of transporters
and channels are expressed in both the kidney and inner ear,
including pendrin (Lang et al., 2007). Understanding the func-
tional significance of these genes in one system can shed
more light on its role in other systems and thus contribute to
a wide systemic networking of gene function.
Junctional Complex and Tight Junctions
The inner ear and its membranous labyrinth is composed of
a rich network of epithelial cells that contribute to the compart-
mentalization of two types of inner ear fluids, the K+-rich
endolymph and Na+-rich perilymph. The high concentration of
potassium (K+) within the endolymph is crucial for depolarization
of the sensory hair cells upon stimulation driven by sound. Due to
their unique ionic composition, themechanical barrier created by
different epithelial cells is crucial to prevent leakage of ions
between these fluid-filled compartments. Paramount to this
function are the tight junctions proteins that contribute to the
contact between neighboring cells, thus maintaining the tight
junctional barrier surrounding the scala media (endolymph).
Several genes are essential for the molecular composition of
tight junctions in the cochlea, including CLDN14, TRIC, and
TJP2, have been linked with different forms of NSHL. Mutations
in CLDN14 encoding the tight junction claudin-14 cause
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Additional members of the claudin family of proteins, claudin-
11 and claudin-9, are essential for auditory function in mice
(Gow et al., 2004; Kitajiri et al., 2004; Nakano et al., 2009) The
multiprotein complex of tight junctions is composed of integral
and peripheral membrane proteins (Tsukita et al., 2001). The
claudin family consists of more than 24 members of integral
membrane proteins with four transmembrane domains being
the main structural components of intramembrane strands.
Changes in claudin composition of a junction that vary between
different epithelia define the selectivity of ions within the paracel-
lular pathway. In addition to their function in barrier formation and
adhesion, the integral membrane proteins regulate cell polariza-
tion and recruit signaling molecules that regulate different cell
mechanisms such as proliferation, differentiation, and gene
expression (Matter and Balda, 2003). In the inner ear, claudin-
14 is expressed in the sensory epithelium of the organ of Corti,
restricted to tight junctions of the reticular lamina, a mosaic of
sensory hair cells and different supporting cells (Ben-Yosef
et al., 2003). Claudin-14 is also expressed in the vestibular appa-
ratus of the inner ear, in the kidney and liver, although none of
these systems have been shown to be affected in claudin-14
deaf individuals. The auditory system may lack the compensa-
tory components essential for the loss of claudin-14 function
(Wilcox et al., 2001). Claudin-14 null mice develop normal endo-
cochlear potentials but show rapid OHC degeneration followed
by slower IHC loss observed during the first 3 weeks of life.
Freeze-fracture replicas show preserved morphological struc-
ture of tight junction strands, suggesting that other claudins
participate in the cohesion of the cochlear junctional complex.
Thus, the elimination of one claudin from a tight junction complex
may have a functional but not necessary structural effect on
strand integrity. Expression of claudin-14 inMDCKepithelial cells
was shown to increase paracellular resistance via selective
discrimination against cations (Ben-Yosef et al., 2003). In the
inner ear, claudin-14 has been suggested to have a functional
significance inmaintaining theparacellular barrier against cations
in the cochlear sensory epithelium. The absence of claudin-14
increases the permeability of cation that results in elevated K+
concentration in the spaces between the outer hair cells (space
of Nuel). Exposure of the basolateral membranes to this toxic
environment causes prolonged depolarization of the outer hair
cells that may lead to cell death (Zenner et al., 1994).
Tricellulin, encoded by the TRIC gene, is another tight junction
protein important for auditory function. In contrast to claudins
that mainly maintain bi-cellular tight junctions, tricellulin is
enriched at the junctions between three epithelial cells (Ikenou-
chi et al., 2005). Several human mutations in TRIC have been
linked with moderate-to-profound NSHL DFNB49 (Riazuddin
et al., 2006). TheDFNB49 locus was originally mapped to a chro-
mosomal region that also contains the OCLN gene encoding
a tight junction protein known as occludin. Occludin is an integral
membrane protein associated with the intramembrane claudin-
based strands of the junctional complex (Feldman et al., 2005;
Furuse et al., 1993). Similar to claudins, occludin has four trans-
membrane domains and was linked to various junctional
functions, including regulation of size-selective diffusion of para-
cellular permeability (Balda et al., 2000). Utilizing carboxy andaminoterminal cytoplasmic domains, both claudins and occludin
interact with ameshwork of cytoplasmic densely packed periph-
eral proteins that stabilize the junctional complex and serve as
a scaffolding and a signaling center (Guillemot et al., 2008).
A prominent example for these interactions is demonstrated by
the tight junction proteins (TJP), TJP1, TJP2, and TJP3 (also
known as ZO-1, ZO-2, and ZO-3) that interacts with the cyto-
plasmic domains of different integral membrane proteins such
as claudins (Itoh et al., 1999) and occludin (Li et al., 2005). Tricel-
lulin shares a conserved domain with occludin in its C-terminal
cytoplasmic domain (occludin-ELL domain) that mediates the
interaction with Tjp1 (Riazuddin et al., 2006). This domain was
shown to be affected in the TRICmutation that causes deafness
in humans (Riazuddin et al., 2006). Tjp proteins contain multiple
domains for protein-protein interactions, including three PDZ
domains and an SH3 domain, through which they interact with
membrane proteins, cytoskeleton components and signaling
molecules. In particular, Tjp1 was shown to directly interact
with F-actin, forming a molecular bridge between integral
membrane proteins such as claudins and tricellulin and the cyto-
skeleton (Fanning et al., 2002). In the inner ear, tricellulin is
expressed in tricellular junctions between supporting and hair
cells. Humanmutations in TRIC lead to a truncated form of tricel-
lulin protein that lacks the functional domain (occludin-ELL), fails
to interact with Tjp1, and leads to deafness (Riazuddin et al.,
2006). It has been suggested that this mutation interferes with
the ability to connect cytoskeletal actin of the hair cell cuticular
plate to its associated stereocilia rootlets. Such structural defor-
mation may affect the rigidity of the reticular lamina of the organ
of Corti, leading to possible defects in stereocilia microdeflec-
tions, as well as structural aberrations of the sensory epithelium
associated with mechanical stress of auditory function.
Recently, a mutation in a different member of the TJP proteins,
TJP2 encoded by the TJP2 gene, was linked with progressive
NSHL DFNA51 (Walsh et al., 2010a). A tandem inverted genomic
duplication that includes the entire wild-type TJP2 gene leads to
overexpression of both transcript and protein levels within
lymphoblasts derived from affected individuals. Interestingly,
the TJP2 duplication affects the expression of apoptosis-related
genes in the lymphoblasts. In the inner ear, Tjp2 was shown to be
expressed in tight junctions between hair cells and supporting
cells of the organ of Corti. Similar to other TJP proteins, Tjp2
mediates a wide spectrum of cellular signaling via its multiple
protein-protein interaction domains (Guillemot et al., 2008).
Tjp2 has also been reported to localize to the nucleus, where it
interacts with several transcription factors, as well as with
DNA-binding protein scaffold attachment factor B (SAFB)
(Huerta et al., 2007; Traweger et al., 2003). It has been suggested
that increased expression of TJP2 in the cochlear sensory
epithelium of affected individuals alters the native intracellular
signaling mediated by its normal function (Walsh et al., 2010a).
As a result, deleterious changes in apoptosis-related gene
expression in the sensory cells may lead to hair cell death and
hearing loss.
Synaptic Transmission and the Auditory Pathway
Most forms of hearing loss interfere with the normal function of
the cochlear sensory hair cells, which fail to transduce theNeuron 68, October 21, 2010 ª2010 Elsevier Inc. 301
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properly activated by sound but the electrical signal transmis-
sion from the cochlea to the brain along the auditory pathway
is impaired. A relatively rare hearing disorder, coined by the
nosological term auditory neuropathy, is caused by the improper
function of the auditory nerve, while the cochlea sensory
machinery is normal (Starr et al., 1996). Clinically, patients with
auditory neuropathy show a significantly higher degree of
speech disability as compared to patients with sensorineural
hearing impairment with similar hearing thresholds (Starr et al.,
2000). The clinical diagnostic criteria for auditory neuropathy
includes abnormal auditory brainstem response (ABR) test and
preserved otoacoustic emission (OAE), an indication of func-
tional OHCs. Four genes have been discovered in association
with auditory neuropathy. The role of the proteins encoded by
these genes is well established for VGLUT3 (SLC17A8), partly
known for otoferlin (OTOF), and yet to be determined for pejvakin
(PJVK) and diaphanous-3 (DIAPH3).
The primary lesion in auditory neuropathy patients can be
located in the hair cells, the adjacent nerve terminals, the audi-
tory nerve, the intervening synapses, or any other location further
downstream of the auditory pathway. Interestingly, both
VGLUT3 and otoferlin are key components of the afferent
synapse of cochlear inner hair cells, which is the first synapse
in the auditory pathway. VGLUT3 belongs to a group of three
subtypes of the vesicular glutamate transporter (VGLUT 1–3).
Glutamate is the principal excitatory neurotransmitter at the
inner hair cell afferent synapse, as well as in the mammalian
central nervous system (CNS) (Puel, 1995; Santos et al., 2009).
The accumulation of glutamate in synaptic vesicles depends
on the activity of the different VGLUTs isoforms. The role of the
unconventional vesicular glutamate transporter VGLUT3 in
synaptic transmission of the inner hair cell was first established
in knockout mice (Seal et al., 2008). This work led to the identifi-
cation of the SLC17A8 gene, which encodes VGLUT3 and
underlies NSHL (Ruel et al., 2008). The affected amino acid
residue of VGLUT3 in DFNA25 individuals is highly conserved
among all VGLUT isoforms, suggesting its functional role. Vglut3
null mice show no response to sound measured by auditory
brainstem response but preserved OAE indicates normal OHC
function (Seal et al., 2008). Significantly, in the inner ear, Vglut3
is selectively expressed in cochlear IHCs. The synaptic vesicle
of IHCs is loaded with glutamate mediated by the Vglut3 trans-
porter. Accumulated glutamate synaptic vesicles then fuse
with the plasma membrane, releasing their contents onto recep-
tors of auditory-nerve terminals. Depletion of Vglut3 protein
leads to a severe auditory synaptic deficiency due to the loss
of glutamate uptake and release.
Otoferlin, encoded by OTOF, participates in the late step of
synaptic-vesicle exocytosis in cochlear IHCs and has also
been linked with auditory neuropathy (DFNB9) (Chaı¨b et al.,
1996; Yasunaga et al., 1999). Otoferlin is a membrane-anchored
cytosolic protein present as both long and short isoform classes
(Yasunaga et al., 2000). All otoferlin isoforms share a C-terminal
transmembrane (TM) domain, while they vary in the number of
conserved C2 domains. The long isoforms were detected in
both human and mouse, whereas the short isoforms were
observed only in humans. The long isoforms contain six C2302 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.domains (C2A–F), whereas the short ones contain two C2
domains. Interestingly, in all DFNB9 mutations the long isoform
is affected and is therefore required for normal auditory function
in humans (Yasunaga et al., 2000). Otoferlin is a FER-1-like
protein, a human homolog of the spermatogenesis factor
FER-1, first described in C. elegans (Achanzar and Ward,
1997). Via its C2 domains, FER-1 mediates Ca2+ dependent
lipid-processing events, crucial for vesicle fusion and regulated
exocytosis (Washington and Ward, 2006). Prominently, the
majority of the DFNB9 mutations in otoferlin are distributed
within the C2 domain, pointing out the functional necessity
of this domain. Targeted mutagenesis of the C2 domains of
FER-1 by single amino acid substitutions leads to defective
membranous organelle fusion. Otoferlin also shows sequence
similarity with dysferlin, another human homolog of FER-1,
essential for vesicle fusion in muscle. Human mutations in dys-
ferlin are associated with limb girdle muscular dystrophy and
Miyoshi myopathy (Bashir et al., 1998; Liu et al., 1998). Based
on well-established protein homology, otoferlin was proposed
to mediate Ca2+-triggered vesicle membrane fusions in IHCs.
Further studies in this direction established the role of otoferlin
as a unique calcium sensor for neurotransmitter release at the
site of the auditory ribbon synapse (Roux et al., 2006). Detailed
immunolocalization analysis showed that otoferlin expression
is restricted to the IHC, with strong labeling at the baso-lateral
synaptic region. Association of otoferlin with synaptic vesicles
was further corroborated by its interactions with syntaxin1 and
SNAP25, two members of the SNARE complex, as well as with
the Cav1.3 calcium channel (Ramakrishnan et al., 2009; Safied-
dine andWenthold, 1999). The interactions of otoferlin with these
proteins were shown to be Ca2+ dependent, mediated by the C2
Ca2+ binding domains. Otoferlin-deficient mice lacking Otof
exons 14 and 15, which encode most of its C2C domain, are
profoundly deaf (Roux et al., 2006). Strikingly, Otof/ mice
show no visible ABR but have normal recordings of OAEs,
mimicking the human phenotype and confirming auditory
neuropathy. Importantly, ABR could be elicited by direct electri-
cal stimuli, indicating that auditory neurons are not the target
cells of the otoferlin deficit. Furthermore, transmission electron
microscopy of Otof/ ribbon synapses showed normal devel-
opment, suggesting that otoferlin is not essential for their forma-
tion. However, electrophysiological studies of presynaptic
function of IHCs revealed a severe disruption of Ca2+-triggered
exocytosis in the absence of otoferlin. Additional work has
further established the critical function of otoferlin in calcium-
dependent exocytosis and vesicle fusion at auditory hair cells
synapses (Beurg et al., 2008; Dulon et al., 2009).
Recent work on pachanga, an additional mouse model for
DFNB9, has yielded valuable insights into the molecular function
of otoferlin. Originating in an ENU mutagenesis screen, the
pachanga deaf mice, OtofPga/Pga, carry a missense mutation in
the Otof gene, affecting an Asp residue in the C2F domain
(Schwander et al., 2007). Significantly, as previously reported
for synaptotagmin, Asp residues in C2 domains are essential
for Ca2+ binding (Sutton et al., 1995). As opposed to the Otof/
mice that lack otoferlin expression, OtofPga/Pga mice provide an
opportunity to study its function in the presence of the aberrant
protein. Immunohistochemistry confirmed that OtofPga/Pga mice
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mice. Similar to the otoferlin null mice, OtofPga/Pga show ABR
thresholds above 90 dB with unaffected OAE, confirming an
auditory neuropathy phenotype and normal function of OHCs.
Electrocochleography studies of cochlear function indicated
normal IHC MET and basolateral conductance (Pangrsic et al.,
2010). Nevertheless, the absence of compound action potentials
in response to loud acoustic stimulus narrows down the auditory
defect to the IHC synapse. In vitro studies show that several
characteristics of synaptic activity remain normal in the mutants,
including vesicle docking, Ca2+ signaling, and fusion. However,
OtofPga/Pga mice show a significant slowed replenishment of
the readily releasable vesicle pool (RRP). Such a lower rate of
replenished vesicles within the mutant active zone limits the
rate of transmitter release and reduces the neuronal spiking in
response to sound stimulus. Altogether, the variety of studies
on human and Otof mouse models revealed two functions of
otoferlin in vesicle fusion at ribbon synapses (Beurg et al.,
2008; Dulon et al., 2009) and in vesicle replenishment (Pangrsic
et al., 2010). The impaired function of these processes in auditory
synaptic transmission reveal the pathophysiology underlying
hearing defects of OTOF affected individuals.
Mutations in two additional genes, PJVK and DIAPH3, have
also been linked with auditory neuropathy. PJVK, encoding
pejvakin, was the second gene discovered to be responsible
for nonsyndromic auditory neuropathy (DFNB59) (Delmaghani
et al., 2006). Pejvakin is a 352-residue protein that bears signifi-
cant similarity to DFNA5, another deafness gene (Van Laer et al.,
1998). It has been shown that the DFNA5 gene has a potential
role in the p53-regulated cellular response to DNA damage
(Masuda et al., 2006) and has been identified as a target for
methylation during cancer-related epigenetic events, high-
lighting its tumor suppressive activity (Kim et al., 2008). In the
inner ear, pejvakin is expressed in different cell types, including
the spiral ganglion, the sensory area of the vestibule and in
portions of the organ of Corti. Further expression analysis along
the afferent auditory pathway revealed that pejvakin is localized
to the cochlear nuclei, superior olivary complex and inferior col-
liculus (Delmaghani et al., 2006). A knockin mouse model,
Dfnb59tm1Ugds, containing the human gene targeted by homolo-
gous recombination, show an increase in ABR thresholds with
normal recording of OAEs at the affected frequencies, confirm-
ing these mice as a model for DFNB59 auditory neuropathy.
Dfnb59tm1Ugds mice did not show any gross malformation of
the auditory system or along the auditory pathway. Excluding
neuronal morphological defects such as demyelination sug-
gested that the Dfnb59 mutation is functional rather than struc-
tural. The identification of a novel mousemodel, sirtaki, identified
in a recessive ENU screen, demonstrated that pejvakin hasmore
diverse mechanisms of pathogenesis (Schwander et al., 2007).
Sirtaki mice have a premature stop codon, leading to a deletion
of 62 amino acids of the pejvakin protein. Interestingly, unlike the
neuropathy phenotype of Dfnb59tm1Ugds mice, the sirtaki allele
leads to progressive hearing loss in mice. Further OAE testing
on sirtaki mice showed defects in OHCs, suggesting that pejva-
kin is necessary for their development and function. A different
genetic background of these mice, as well as the different muta-
tion in the Pjvk gene, can explain some of this phenotypic varia-tion. Consistent with this observation, identification of a novel
PJVK null mutation in a consanguineous Iranian family
was shown to be associated with progressive hearing loss
(Hashemzadeh Chaleshtori et al., 2007; Schwander et al.,
2007). Correlating with the allelic variation in humans, the
different phenotypic characteristics of the sirtaki allele, distinc-
tive from other pejvakin mouse models, suggests that pejvakin
affects both hair cells and neurons of auditory machinery.
Finally, the Diaphanous homolog 3 (DIAPH3), was recently
added to the list of auditory neuropathy-related genes. The
DIAPH3 gene originally mapped to the AUNA1 (auditory neurop-
athy, dominant, 1) locus in an American family (Kim et al., 2004).
Interestingly, as opposed to other auditory neuropathy genes
that bear mutations within the coding regions (Delmaghani
et al., 2006; Yasunaga et al., 1999), sequencing of all exons of
DIAPH3 revealed a mutation within the 50 untranslated region
(UTR). This mutation was detected within a GC box consensus
sequence upstream to the translation initiation point of the
mature mRNA. Several transcription factors belonging to the
Sp1 and Kru¨ppel-like protein families are known to bind to this
highly conserved GC element, functioning as either repressors
or activators of the translation machinery (Kaczynski et al.,
2003). Analysis of lymphoblastoid cells isolated from affected
individuals revealed 2- to 3-fold higher DIAPH3 mRNA expres-
sion, detected by genome-wide expression arrays and quantita-
tive RT-PCR (Schoen et al., 2010). Therefore, the DIAPH3
mutation was proposed to have a gain of function effect among
AUNA1 affected individuals (Schoen et al., 2010). Furthermore,
expression of constitutively active form of diaphanous protein
in Drosophila leads to impaired response to sound by the John-
ston’s organ, JO. Future characterization of additional animal
models will help to elucidate the possible role of DIAPH3 in
synapses or neurons of the auditory pathway expanding the
understanding of its underlying molecular mechanisms.
Current Implications for Diagnostics and Therapy
Worldwide studies of the large variety of deafness genes are
emerging rapidly. Themost obvious and applicable clinical impli-
cation for gene discovery is diagnosis. Although the benefit of
genetics studies for therapeutic approaches is still limited, in
some cases genetics diagnosis is valuable. Auditory neuropathy
provides a good example in this respect. Cochlear implantation
among children with auditory neuropathy shows mixed results
(Mason et al., 2003; Teagle et al., 2010). This should come as
no surprise, since cochlear implants bypass the cochlear
sensory cells but are limited when the lesion is further upstream
of the afferent auditory pathway. Strikingly, cochlear implanta-
tion among DFNB9 patients with auditory neuropathy as a result
of OTOF mutations is consistently successful as compared to
other auditory neuropathies (Rodrı´guez-Ballesteros et al.,
2003). The comprehensive understanding of OTOF pathophysi-
ology in ribbon synapses of IHCs correlates with the successful
cochlear implantations that bypass the IHCs, delivering electrical
signals directly to the intact auditory nerve fibers. Such focused
insight about the defective lesion along the auditory pathway
based on genetics studies has provided clinics with the advan-
tage to predict the efficacy of different therapeutic approaches,
such as determining compatibility for cochlear implants.Neuron 68, October 21, 2010 ª2010 Elsevier Inc. 303
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contributed to the prevention of some forms of hearing loss.
Mutations in the mitochondrial 12S rRNA have been shown to
be associated with high risk for aminoglycoside-induced hearing
loss (Fischel-Ghodsian, 1999). Pharmacogenomic testing for
such mutations is currently minimizing the risk for aminoglyco-
side-induced ototoxicity among groups of patients that are
commonly treated with this drug (Bardien et al., 2009; Veenstra
et al., 2007). Understanding the molecular pathogenesis associ-
ated with drug susceptibility of such genetic mutations can help
promote the development of alternative drugs with similar effi-
cacy yet significant reduced toxicity (Nudelman et al., 2009).
Looking toward the Future
The ‘‘holy grail’’ of auditory genetic studies is to use the enor-
mous knowledge gathered about genes for hearing impairment
and their function and apply it to advancing therapeutics for
hearing. Whereas current gene therapy approaches are under
development in animal models and in some human diseases,
for example, Leber’s congenital amaurosis, an eye disease in hu-
mans (Maguire et al., 2009), it is far from being applicable in the
inner ear in humans. Several strategies are under development,
taking advantage of high-throughput platforms and models for
the human inner ear. One such strategy is wide screening of
drug compounds for hearing loss using the zebrafish lateral
line (Ou et al., 2009, 2010). This powerful high-throughput
screening has led to the discovery of several compounds that
protect the sensory cells from aminoglycoside-induced death.
Moreover, this technique enables routine testing of the toxicity
and efficacy of new drugs on the auditory system. Such an inno-
vative approach may eventually enable the development of
a protective medication for hearing loss, tailored to the specific
genetic mutation of an individual patient.
Therapeutics in the inner ear field has focused on the regener-
ation capacity of hair cells (reviewed in Collado et al., 2008). The
ability of avians to regenerate hair cells (Corwin and Cotanche,
1988; Ryals and Rubel, 1988) has triggered scientists to study
the unique features that enable this capacity (Stone and
Cotanche, 2007). Ultimately, revealing the mechanism of hair
cell regeneration, not yet optimal in vertebrates, may pave the
way to rescue hearing in hearing impaired patients. Recent
advances in hearing therapeutics have also taken advantage of
the stem cell field. Utilizing the pluripotency characteristics of
embryonic stem cells, laboratories have devoted their efforts to
differentiating these cells into hair cell-like structures (Coleman
et al., 2007; Oshima et al., 2010). Ideally, hair cells derived
from embryonic stem cells will be tested to recapitulate the
morphological and functional properties of the cochlear hair
cell, initiating stem cell-based treatment for hearing impairment.
Another feasible approach is to enhance the capabilities of
cochlear implants, a prosthesis that directly stimulates the nerve
fibers of the cochlea, a current rehabilitation option for the
population with severe to profound hearing loss (Shibata and
Raphael, 2010). These efforts include, most recently, injection
of adenoviral vectors with neurotrophins in order to generate
resprouting of auditory peripheral fibers following hearing loss,
which are required for the implants to electrically stimulate spiral
ganglion neurons (Wise et al., 2010). Altogether, these emerging304 Neuron 68, October 21, 2010 ª2010 Elsevier Inc.strategies are promising and hopefully will converge into
combined future therapeutic approaches for deafness and
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